Back to blog

Medication Deprescribing: The Science of Safely Tapering Drugs You No Longer Need

Health Intelligence TeamJune 19, 20266 min read
Medication Deprescribing: The Science of Safely Tapering Drugs You No Longer Need

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making changes to your medications, supplements, or health regimen.

Medication Deprescribing: The Science of Safely Tapering Drugs You No Longer Need

Most conversations about medications focus on starting them. But what about stopping them? For millions of people—especially older adults managing multiple chronic conditions—the question of which medications to stop is just as important as which ones to take.

Deprescribing is the systematic, evidence-based process of reducing or discontinuing medications that are no longer necessary, are causing harm, or whose risks now outweigh their benefits. Far from being a passive act of "giving up" on treatment, deprescribing is an active, clinician-guided strategy to improve health outcomes and quality of life.

What Is Deprescribing and Why Does It Matter?

According to a landmark review published in JAMA Internal Medicine, approximately 30–40% of older adults take at least one medication that is potentially inappropriate for their age or condition ([source](https://pubmed.ncbi.nlm.nih.gov/25798575/)). The World Health Organization (WHO) has identified polypharmacy—the concurrent use of five or more medications—as a major global patient safety challenge ([WHO Medication Safety Report](https://www.who.int/publications/i/item/medication-without-harm-global-patient-safety-challenge)).

Deprescribing matters because:

  • Medications accumulate over time. A drug started for a short-term problem may continue indefinitely by default.
  • Health conditions change. A medication appropriate at age 55 may be unnecessary or harmful at age 75.
  • Drug interactions multiply with each added medication. The risk of a clinically significant interaction rises sharply with each additional drug.
  • Side effects are often misattributed. Symptoms like fatigue, cognitive fog, or falls are frequently caused by medications—not by aging itself.
  • Which Medications Are Most Commonly Deprescribed?

    Research from the Deprescribing Research Network and published guidelines identify several drug classes as high-priority candidates for deprescribing:

    Proton Pump Inhibitors (PPIs)

    PPIs like omeprazole and pantoprazole are among the most overprescribed drug classes worldwide. While effective for short-term acid suppression, long-term use is associated with magnesium deficiency, increased fracture risk, and Clostridioides difficile infection ([NIH/NLM](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641836/)). Many patients who were started on PPIs for stress ulcer prophylaxis during hospitalization continue them indefinitely without reassessment.

    Benzodiazepines and Sleep Aids

    Drugs like lorazepam, diazepam, and zolpidem are associated with falls, cognitive impairment, and dependence—particularly in older adults. The American Geriatrics Society's Beers Criteria explicitly recommends avoiding these agents in adults over 65 ([AGS Beers Criteria](https://www.americangeriatrics.org/media-center/news/updated-ags-beers-criteriar-potentially-inappropriate-medication-use-older)). Tapering these medications slowly under medical supervision can restore cognitive clarity and reduce fall risk.

    Statins in Advanced Age or Terminal Illness

    While statins are highly effective for primary and secondary cardiovascular prevention in middle-aged adults, their benefit-risk ratio shifts in very elderly patients or those with limited life expectancy. A 2015 study in JAMA Internal Medicine found that discontinuing statins in patients with limited life expectancy improved quality of life without increasing cardiovascular events ([PubMed](https://pubmed.ncbi.nlm.nih.gov/25798575/)).

    Antihypertensives

    Blood pressure targets and medication needs change with age. Aggressive blood pressure lowering in frail older adults can cause orthostatic hypotension, syncope, and falls. Reassessing antihypertensive regimens—especially after significant weight loss or lifestyle changes—is a key deprescribing opportunity.

    Antidiabetic Agents

    As patients age or lose weight, their glycemic control often improves, making previously necessary diabetes medications a source of hypoglycemia risk rather than benefit. The American Diabetes Association recommends relaxing HbA1c targets in older adults with complex health situations ([ADA Standards of Care](https://diabetesjournals.org/care/article/46/Supplement_1/S140/148057)).

    The Deprescribing Process: How It Works

    Deprescribing is not simply stopping a medication. It is a structured clinical process that typically involves:

    1. Medication Reconciliation

    A complete, accurate list of all medications—including over-the-counter drugs, supplements, and herbal products—is compiled. This is often the first step in identifying redundant, interacting, or unnecessary agents.

    2. Benefit-Risk Reassessment

    Each medication is evaluated against the patient's current health status, goals of care, and life expectancy. Tools like the Medication Appropriateness Index (MAI) and STOPP/START criteria provide structured frameworks for this assessment ([PubMed STOPP/START](https://pubmed.ncbi.nlm.nih.gov/25324358/)).

    3. Prioritization

    Not all medications can or should be stopped simultaneously. Clinicians prioritize based on:

  • Severity of potential harm
  • Likelihood of benefit
  • Patient preferences and goals
  • Ease of tapering
  • 4. Tapering vs. Abrupt Discontinuation

    Some medications must be tapered gradually to avoid withdrawal or rebound effects:

  • Benzodiazepines: Typically reduced by 10–25% every 1–2 weeks
  • SSRIs/SNRIs: Tapered over weeks to months to prevent discontinuation syndrome
  • Beta-blockers: Gradual reduction to prevent rebound hypertension or angina
  • Corticosteroids: Slow taper to allow adrenal axis recovery
  • Other medications—like PPIs or statins—can often be stopped more abruptly, though rebound acid hypersecretion may occur with PPIs.

    5. Monitoring After Deprescribing

    Close follow-up is essential. Patients should be monitored for:

  • Return of the original condition
  • Withdrawal symptoms
  • Changes in lab values (e.g., blood pressure, blood glucose, lipids)
  • Improvement in symptoms previously attributed to aging
  • How to Have the Deprescribing Conversation with Your Doctor

    Many patients feel reluctant to question their medications, and many clinicians are hesitant to stop drugs started by another provider. Here's how to approach the conversation:

  • Bring a complete medication list to every appointment, including supplements and OTC drugs.
  • Ask specifically: "Is each of these medications still necessary for me?"
  • Share your concerns: Side effects, cost, pill burden, and quality of life are all valid reasons to reassess.
  • Use resources like [Deprescribing.org](https://deprescribing.org/), which provides patient-friendly guides for specific drug classes.
  • Request a medication review from your pharmacist—many pharmacies offer comprehensive medication reviews at no cost.
  • What the Research Shows About Outcomes

    The evidence for deprescribing is growing. A 2021 systematic review in Age and Ageing found that structured deprescribing interventions reduced the number of inappropriate medications, improved quality of life, and in some studies reduced mortality in older adults ([PubMed](https://pubmed.ncbi.nlm.nih.gov/33693498/)). Patients who successfully deprescribed benzodiazepines reported improved sleep quality, better cognitive function, and reduced anxiety—often the opposite of what they feared.

    Key Takeaways

  • Deprescribing is an evidence-based, clinician-guided process—not simply stopping medications on your own.
  • PPIs, benzodiazepines, statins in advanced age, antihypertensives, and antidiabetic agents are among the most common deprescribing targets.
  • Some medications require gradual tapering to avoid withdrawal or rebound effects.
  • Regular medication reviews—at least annually—are essential for anyone taking multiple medications.
  • Patient-clinician partnership is the cornerstone of safe deprescribing.

---

Take Control of Your Health Data

Ready to cross-reference your medications, supplements, and lab results in one place? [Health Intelligence Analyzer](/) helps you identify potential interactions, flag abnormal lab values, and optimize your health regimen with AI-powered insights. Start your free analysis today.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before making changes to your health regimen.

Get personalized insights for your health

Our AI analyzes your specific medications, supplements, and conditions to find interactions and optimization opportunities.

Try Free

Get weekly health insights

Science-backed tips on medications, supplements, nutrition, and lab results — delivered free to your inbox.